David J. Blanchard

Array ( [id] => 5921335 [patent_doc_number] => 20060240003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Humanised antibodies to the epidermal growth factor receptor' [patent_app_type] => utility [patent_app_number] => 11/478657 [patent_app_country] => US [patent_app_date] => 2006-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9117 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240003.pdf [firstpage_image] =>[orig_patent_app_number] => 11478657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834717 [patent_doc_number] => 20060246548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'CE7-specific redirected immune cells' [patent_app_type] => utility [patent_app_number] => 11/477572 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15561 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246548.pdf [firstpage_image] =>[orig_patent_app_number] => 11477572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834247 [patent_doc_number] => 20060246077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Use of antibodies against the MUC18 antigen' [patent_app_type] => utility [patent_app_number] => 11/479339 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 16628 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246077.pdf [firstpage_image] =>[orig_patent_app_number] => 11479339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5075236 [patent_doc_number] => 20070015211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Conformer-specific antibodies and method of use, thereof' [patent_app_type] => utility [patent_app_number] => 11/473460 [patent_app_country] => US [patent_app_date] => 2006-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14372 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015211.pdf [firstpage_image] =>[orig_patent_app_number] => 11473460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5852012 [patent_doc_number] => 20060235203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'MN gene and protein' [patent_app_type] => utility [patent_app_number] => 11/448576 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 40824 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235203.pdf [firstpage_image] =>[orig_patent_app_number] => 11448576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141769 [patent_doc_number] => 20070003985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Specific mucin expression as a marker for pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 11/444123 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12374 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003985.pdf [firstpage_image] =>[orig_patent_app_number] => 11444123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784301 [patent_doc_number] => 20060204492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Compositions and methods for producing enhanced antibodies' [patent_app_type] => utility [patent_app_number] => 11/439071 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27381 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204492.pdf [firstpage_image] =>[orig_patent_app_number] => 11439071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141331 [patent_doc_number] => 20070003547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Super humanized antibodies' [patent_app_type] => utility [patent_app_number] => 11/432734 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12062 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003547.pdf [firstpage_image] =>[orig_patent_app_number] => 11432734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672101 [patent_doc_number] => 20060177455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same' [patent_app_type] => utility [patent_app_number] => 11/400241 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 18367 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177455.pdf [firstpage_image] =>[orig_patent_app_number] => 11400241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704803 [patent_doc_number] => 20060193851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Human anti-factor IX/IXa antibodies' [patent_app_type] => utility [patent_app_number] => 11/396115 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24723 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193851.pdf [firstpage_image] =>[orig_patent_app_number] => 11396115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609321 [patent_doc_number] => 20060270837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors' [patent_app_type] => utility [patent_app_number] => 11/391384 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 138991 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270837.pdf [firstpage_image] =>[orig_patent_app_number] => 11391384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672100 [patent_doc_number] => 20060177454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Method of promoting an immune response with a bispecific antibody' [patent_app_type] => utility [patent_app_number] => 11/391833 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10242 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177454.pdf [firstpage_image] =>[orig_patent_app_number] => 11391833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834265 [patent_doc_number] => 20060246095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Multiepitope polypeptides for cancer immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/388794 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18778 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246095.pdf [firstpage_image] =>[orig_patent_app_number] => 11388794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5023802 [patent_doc_number] => 20070149768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Specific human antibodies for selective cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/388025 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 32749 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149768.pdf [firstpage_image] =>[orig_patent_app_number] => 11388025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5857887 [patent_doc_number] => 20060228350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Framework-shuffling of antibodies' [patent_app_type] => utility [patent_app_number] => 11/377148 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 93796 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228350.pdf [firstpage_image] =>[orig_patent_app_number] => 11377148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850609 [patent_doc_number] => 20060233800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Biological products' [patent_app_type] => utility [patent_app_number] => 11/374231 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16724 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233800.pdf [firstpage_image] =>[orig_patent_app_number] => 11374231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699551 [patent_doc_number] => 20060216235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/370255 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11620 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216235.pdf [firstpage_image] =>[orig_patent_app_number] => 11370255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699550 [patent_doc_number] => 20060216234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/370203 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11660 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216234.pdf [firstpage_image] =>[orig_patent_app_number] => 11370203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655228 [patent_doc_number] => 20060140963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD59' [patent_app_type] => utility [patent_app_number] => 11/361153 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17484 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140963.pdf [firstpage_image] =>[orig_patent_app_number] => 11361153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850600 [patent_doc_number] => 20060233791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Anti-CD19 antibodies and uses in oncology' [patent_app_type] => utility [patent_app_number] => 11/355905 [patent_app_country] => US [patent_app_date] => 2006-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 62454 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233791.pdf [firstpage_image] =>[orig_patent_app_number] => 11355905 [rel_patent_id] =>[rel_patent_doc_number] =>)